Results of preliminary phase II study of ublituximab in RRMS

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Results of preliminary phase II study of ublituximab in RRMS

Post by MSUK » Thu Jun 29, 2017 4:28 am

Rapid and robust B-cell depletion reported in preliminary phase II study of ublituximab

Relapsing remitting multiple sclerosis (RRMS) patients treated with ublituximab (TG-1101) have exhibited a median B-cell depletion of 99% at week four of an ongoing five month study, conducted by TG Therapeutics, Inc...Read more - http://www.ms-uk.org/rapid-and-robust-b ... mab-290617
MS-UK - http://www.ms-uk.org/

User avatar
frodo
Family Elder
Posts: 1330
Joined: Wed Dec 02, 2009 3:00 pm
Contact:

Re: Results of preliminary phase II study of ublituximab in

Post by frodo » Sun Jul 02, 2017 10:15 pm

Thanks again. The news page of MS-UK is currently the best source of information in the web.

User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Re: Results of preliminary phase II study of ublituximab in

Post by MSUK » Sun Jul 02, 2017 11:21 pm

Thank you for this feedback, means a lot :-D
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post